Выпуск №3 за 2013 год
Introduction: It has been found that the
leading pathophysiological mechanism of
arteriogenic erectile dysfunction (ED) is
a violation of the endothelial function of
cavernous arteries. Given the...
Выпуск №2 за 2013 год
The inhibitors of the phosphodiesterase
type 5 (iPDE-5) are today the first line
agents for the therapy of the erectile
dysfunction (ED). The data regarding
their effect on the male fertility is...
Выпуск №3 за 2012 год
Inhibitors of phosphodiesterase type 5 are the first line in the treatment of erectile dysfunction. Recent publications indicate ambiguous influence on spermatogenesis – from stimulating up to...
Выпуск №1 за 2013 год
Phosphodiesterase type 5 inhibitors
(iPDE-5) are the first line medications
for erectile dysfunction in men. Given
that all of them are highly selective,
nevertheless they can have effects on
the...